Project Grant HT94252410291
Award Date 4/15/24
Completion Date 4/14/26
Dollars Obligated $528K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98109, USA
Similar Awards
- The federal Project Grant award of $1,578,836.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance) in developing and exploiting a third-generation prostate cancer dependency map to identify cancer vulnerabilities and treatment targets. The award, which runs from August 1, 2024 to July 31, 2027, will enable the research organization to conduct innovative...
- The U.S. Department of Defense's Defense Health Agency awarded a $526,042 Project Grant to the Fred Hutchinson Cancer Center, doing business as the Seattle Cancer Care Alliance, to support research aimed at identifying and targeting mechanisms of prostate cancer therapy resistance driven by the tumor microenvironment. The project will be conducted over a 2-year period from May 1, 2024 to April 30, 2026 under the Military Medical Research and Development program (CFDA 12.420). This research grant...
- The U.S. Defense Health Agency awarded a $5,149,107 Project Grant to the Fred Hutchinson Cancer Center in Seattle, WA, under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at "Defining Human Correlates of Super-Evasive Disseminated Tumor Cells, Their Pathological Relevance and How to Eradicate Them" over the period of July 1, 2025 to June 30, 2029. The research will be conducted by the prominent non-profit medical research...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,927,373.00 to the Fred Hutchinson Cancer Center in Seattle, WA to support the "Development of Targeted Therapies for Metastatic Prostate Cancers Classified by Subtypes of DNA Repair Deficiency". The 3-year project aims to conduct advanced biomedical research to transform healthcare for military service members, veterans, and the broader...
- Federal Project Grant Award Summary Fred Hutchinson Cancer Center received a $525,847 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period July 15, 2025 through July 14, 2027. The award supports research to define and exploit essential components of the androgen receptor program operative in castration-resistant prostate cancers. This research addresses a critical health challenge affecting military...
- The Defense Health Agency awarded a $1,036,233 Project Grant to the Fred Hutchinson Cancer Research Center under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 through June 2024 to develop more precise molecular classification and targeted treatment of metastatic castration-resistant prostate cancer (MCRPC) through multi-omic analysis of circulating tumor DNA (ctDNA). By leveraging ctDNA analysis, the research aims to transform...
- Fred Hutchinson Cancer Center was awarded a $898,342 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to exploit real-world clinical genomic data to discover biomarkers and address outcome disparity for prostate cancer. Through this award, Fred Hutchinson Cancer Center will leverage existing genomic and clinical data to identify biomarkers...
- Federal Grant Award Summary Fred Hutchinson Cancer Center received a $2.112M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2029. The award supports research focused on preventing liver metastasis by identifying and characterizing the regulators of tumor dormancy, understanding mechanisms by which these regulators are disrupted, and developing strategies to reverse dormancy...
- The Fred Hutchinson Cancer Research Center was awarded a $1,125,843 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) for the period of August 1, 2021 through July 31, 2024. Under this award, Fred Hutchinson Cancer Research Center will define and modulate BRCANESS to improve the precision of prostate cancer therapy. The Military Medical Research and Development program supports biomedical research to transform military...
- The federal Project Grant award, ID HT94252411040, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $879,692 award, with a performance period from September 30, 2024 to September 29, 2027, supports the Fred Hutchinson Cancer Center's research on "Combinatorial Phenotype-Targeted Therapy to Overcome Mechanisms Driving Prostate Cancer Treatment Resistance." This innovative research project aims to develop novel...